Revolution Medicines RVMD
NASDAQ RVMD
$178.12 -21.58 (-10.81%)
As of: Nov 5, 2026 · 3:59 PM EST

Revolution Medicines (RVMD) Interest Expenses (2020 - 2026)

Updated

Analysis

Revolution Medicines (RVMD) Interest Expenses (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn -
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn 217.00 Mn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn -
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn -
5 Novartis Ag 313.89 Bn 287.12 Bn - -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn -477.00 Mn
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn 269.00 Mn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn -
10 Revolution Medicines 38.00 Bn 28.20 Bn - 23.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.78 Mn
Mar 31, 2026 12.20 Mn
Dec 31, 2025 11.94 Mn
Sep 30, 2025 11.43 Mn
Jun 30, 2025 867,000.00
Mar 31, 2021 12,000.00
Dec 31, 2020 14,000.00
Sep 30, 2020 17,000.00
Jun 30, 2020 19,000.00
Mar 31, 2020 21,000.00
API Access

Revolution Medicines Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=RVMD&period=max&api_key=YOUR_API_KEY